You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Depakote ER

Showing 1 - 25 of 1,388
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematuria, Bladder Cancer Trial in Syracuse (Valproic Acid)

Completed
  • Hematuria
  • Bladder Cancer
  • Valproic Acid
  • Syracuse, New York
    SUNY Upstate Medical University
Oct 19, 2021

Bipolar I Disorder, Bipolar II Disorder Trial in Cleveland, San Antonio (Lithium, Divalproex, Lamotrigine)

Completed
Has Results
  • Bipolar I Disorder
  • Bipolar II Disorder
  • Cleveland, Ohio
  • +1 more
Aug 17, 2020

Once-Daily Divalproex Extended-Release Tablets Versus

Completed
  • Epilepsy
  • Compliance
  • Orlando, Florida
    Orlando Regional Lucerne Hospital
Mar 3, 2020

Schizophrenia Trial in Saint Louis (Valproate, Placebo)

Completed
Has Results
  • Schizophrenia
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 28, 2020

Bipolar Disorder Trial in San Diego (divalproex ER, quetiapine)

Completed
Has Results
  • Bipolar Disorder
  • San Diego, California
    UCSD Medical Center
Aug 16, 2019

Bipolar Disorder Trial in Cleveland (Divalproex Sodium ER, Placebo)

Completed
Has Results
  • Bipolar Disorder
  • Divalproex Sodium ER
  • Placebo
  • Cleveland, Ohio
    University Hospitals of Cleveland
May 3, 2019

Eating Rate Trial in Wageningen (ultra-processed slow eating rate diet, Ultra-processed fast eating rate diet)

Recruiting
  • Eating Rate
  • ultra-processed slow eating rate diet
  • Ultra-processed fast eating rate diet
  • Wageningen, Gelderland, Netherlands
    Wageningen University
Nov 3, 2023

Prurigo Nodularis Trial in Worldwide (Nalbuphine ER Tablets, Matching Placebo Tablets)

Active, not recruiting
  • Prurigo Nodularis
  • Nalbuphine ER Tablets
  • Matching Placebo Tablets
  • Phoenix, Arizona
  • +69 more
Jan 31, 2023

Chronic Pain, Musculoskeletal Pain, Fibromyalgia Trial in Palo Alto (Empowered Relief for Youth)

Recruiting
  • Chronic Pain
  • +5 more
  • Empowered Relief for Youth
  • Palo Alto, California
    Stanford University
Aug 9, 2023

Esophageal Cancer Trial in Guangzhou (Submucosal Saline Injection, Blue laser Imaging and Magnifying Endoscopy)

Recruiting
  • Esophageal Cancer
  • Submucosal Saline Injection
  • Blue laser Imaging and Magnifying Endoscopy
  • Guangzhou, Guangdong, China
    Cancer center, Sun Yat-sen University
Aug 28, 2023

Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor

Recruiting
  • Breast Cancer
    • Shanghai, Shanghai, China
      Biyun Wang, MD
    Apr 5, 2023

    OCD Trial in Braga (ICBT)

    Recruiting
    • Obsessive-Compulsive Disorder
    • ICBT
    • Braga, Gualtar, Portugal
      Life and Health Sciences Research Institute, School of Medicine,
    Jun 6, 2023

    Breast Cancer Trial in Shijiazhuang (Dalpiciclib, Aromatase inhibitor, Docetaxel injection)

    Recruiting
    • Breast Cancer
    • Shijiazhuang, Hebei, China
      The Fourth Hospital of Hebei Medical University
    Oct 25, 2023

    Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI Trial (drug, procedure, genetic)

    Not yet recruiting
    • Breast Cancer Female
    • +4 more
    • (no location specified)
    Aug 8, 2023

    Breast Cancer Trial in Beijing (18F-FES PET/CT scan)

    Recruiting
    • Breast Cancer
    • 18F-FES PET/CT scan
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Nov 4, 2022

    Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)

    Completed
    • Nalbuphine
    • +2 more
    • Nalbuphine ER
    • Placebo oral tablet
    • Antrim, Northern Ireland, United Kingdom
    • +14 more
    Oct 3, 2022

    Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Springfield, Massachusetts
    • +2 more
    Nov 1, 2022

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

    Recruiting
    • Metastatic Breast Cancer
    • +3 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Sep 26, 2023

    Bipolar Disorder, Schizophrenia Trial in Palo Alto (Divalproex-extended release (DVP-ER), Lithium, Quetiapine)

    Completed
    Has Results
    • Bipolar Disorder
    • Schizophrenia
    • Divalproex-extended release (DVP-ER)
    • +2 more
    • Palo Alto, California
      VA Palo Alto Health Care System
    Jun 19, 2018

    Pain, Chronic Trial (Empowered Relief)

    Not yet recruiting
    • Pain, Chronic
    • Empowered Relief
    • (no location specified)
    Jun 27, 2023

    Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

    Active, not recruiting
    • Estrogen Receptor Positive Breast Cancer
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Feb 1, 2023

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Advanced Triple-Negative Breast Carcinoma
    • +4 more
    • Biopsy
    • +4 more
    • Birmingham, Alabama
    • +9 more
    Aug 31, 2022

    Emotion Regulation Trial in Oxford (Laboratory tasks in middle childhood/pre-adolescence)

    Not yet recruiting
    • Emotion Regulation
    • Laboratory tasks in middle childhood/pre-adolescence
    • Oxford, Ohio
      Miami University Department of Psychology
    Jun 10, 2022

    Epidemic Disease, Infections Trial in Hillerød (virtual Hospital at Home (vHaH))

    Recruiting
    • Epidemic Disease
    • Infections
    • virtual Hospital at Home (vHaH)
    • Hillerød, Denmark
      Department of Pulmonary and Infectious Diseases, Nordsjællands H
    Jun 16, 2023